Relward Pharma Private Limited
About Relward Pharma Private Limited
Data last updated:
Relward Pharma Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299HR2020PTC090989. Its GSTIN is 06AAKCR6054N1ZU (Haryana).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Krishak Malik and Saurabh Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Gurbax Gupta Nanhera Road Vill Nanhera Po Kuldeep Nagar Teh Ambala Cant, Haryana, India – 133004.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.37 Cr, a growth of 44% compared to the previous year. For the same year it recorded a net profit of ₹2.43 Lakh (net margin 0.7%) and EBITDA of ₹20.12 Lakh (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 256% over three years.
As per MCA filings, the company has open charges of ₹55.48 Lakh on record. Court records list 3 cases involving the company, including 3 filed by the company; 3 cases are pending.
Company details
Contact details
Relward Pharma Private Limited's registered office is in Ambala, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Gurbax Gupta Nanhera Road Vill Nanhera Po Kuldeep Nagar Teh Ambala Cant, Haryana, India – 133004
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Relward Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Relward Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Relward Pharma Private Limited, buy the company report.
Financials of Relward Pharma Private Limited
FY 2025 filings availableRelward Pharma Private Limited reported revenue of ₹3.37 Cr (up 44% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 256% over three years, including 44% growth in the latest year. EBITDA rose 155% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹20.12 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.43 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6% | |||
| Net Profit Margin | 0.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Relward Pharma Private Limited, buy the company report.
Board of directors of Relward Pharma Private Limited
Relward Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishak Malik | Director | 18 Nov 2020 | 5 Years 11 Months | Current |
| Saurabh Yadav | Director | 18 Nov 2020 | 5 Years 11 Months | Current |
Peer comparison
Relward Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Oriental Innotech Private Limited | ₹3.37 Cr (FY 2025) | 47.0% | Kolkata, West Bengal, India | |||
| Jashit Fashion India Private Limited | ₹3.37 Cr (FY 2025) | 17.0% | Rani Bagh, Shakur Basti, Delhi, India | |||
| Paras Genetech Private Limited | ₹3.37 Cr (FY 2024) | 5.0% | Ahmedabad, Gujarat, India | |||
| Starker Automation Private Limited | ₹3.37 Cr (FY 2021) | -51.0% | Delhi, India | |||
| Intelx Electrominds Private Limited | ₹3.37 Cr (FY 2025) | 1.0% | Lucknow, Uttar Pradesh, India | |||
| Relward Pharma Private Limitedthis company | ₹3.37 Cr (FY 2024) | ₹2.43 Lakh | 0.7% | 44.0% | Ambala, Haryana, India | |
| Goodward Tradelink Private Limited | ₹3.36 Cr (FY 2025) | -3.0% | Kolkata, West Bengal, India | |||
| Kronicure Biosciences Private Limited | ₹3.36 Cr (FY 2025) | 38.0% | Kolkata, West Bengal, India | |||
| Linear Retrofit Private Limited | ₹3.36 Cr (FY 2024) | Bangalore, Karnataka, India | ||||
| Cani Marketing Private Limited | ₹3.36 Cr (FY 2024) | 62.0% | New Delhi, Delhi, India | |||
| Lemis India Private Limited | ₹3.36 Cr (FY 2024) | -35.0% | Vashi, Maharashtra, India |
To see the full peer comparison of Relward Pharma Private Limited, buy the company report.
Auditor
Relward Pharma Private Limited is audited by V I A N & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V I A N & ASSOCIATES | FY 2022 | 032963N |
Shareholding
The shareholding of Relward Pharma Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Relward Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Nov 2023 | 100845710 | Hdfc Bank Limited | ₹7.02 Lakh | Open | |
| 02 Jun 2023 | 100728466 | State Bank of India | ₹40 Lakh | Open | |
| 28 Mar 2022 | 100573457 | Hdfc Bank Limited | ₹8.46 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
Relward Pharma Private Limited has 3 court cases on record: 3 filed by Relward Pharma. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 3 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against individuals | Pending |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against M/S Jaiswal Traders and 1 other | Pending |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against Ms Leela Traders and 1 other | Pending |
To see the full case history of Relward Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Relward Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Relward Pharma Private Limited has 1 active EPFO establishment as of Apr 01, 2024.
GST
Relward Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAKCR6054N1ZU | Haryana | Active | 22 Dec 2020 |
To see the full GST registrations and return filing status of Relward Pharma Private Limited, buy the company report.
Recent activity
Relward Pharma Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Sunil Malik ceased to be Director on 21 Jan 2026.
Frequently asked questions
Relward Pharma is an active private limited company based in Ambala, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 November 2020 (6+ years old) and is registered under CIN U24299HR2020PTC090989.
Relward Pharma has 2 current directors:
- Krishak Malik - Director
- Saurabh Yadav - Director
The latest financial statements of Relward Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Relward Pharma is 06AAKCR6054N1ZU, registered in Haryana.
The CIN (Corporate Identification Number) of Relward Pharma is U24299HR2020PTC090989. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Relward Pharma has 3 court cases on record: 3 filed by the company. 3 are pending.
Relward Pharma was incorporated on 18 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Relward Pharma by revenue are Oriental Innotech Private Limited, Jashit Fashion India Private Limited, Paras Genetech Private Limited, Starker Automation Private Limited, Intelx Electrominds Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Sunil Malik ceased to be Director on 21 Jan 2026. Krishak Malik was appointed as Director on 18 Nov 2020. Saurabh Yadav was appointed as Director on 18 Nov 2020.
The registered office of Relward Pharma is at CO Gurbax Gupta Nanhera Road Vill Nanhera Po Kuldeep Nagar Teh Ambala Cant, Haryana, India – 133004.
Relward Pharma operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
